Search

everythinglearnresearchcommunity

for

Search:↓

Chemotherapy often causes skin, nail, and hair side effects, significantly impacting quality of life.

Mirtazapine can cause male breast enlargement.

Sacituzumab Govitecan is effective for certain breast cancers but requires careful management of side effects.

Nanoformulations improve drug delivery through the skin, reducing side effects and enhancing effectiveness.

PRP shows promise in treating joint and spine issues, but translating lab results to humans is challenging.

Chinese herbal medicine might help reduce chemotherapy side effects in breast cancer patients, but more high-quality research is needed.

No medications for alcohol dependence have been approved for marketing yet.

Suppressing eIF4E can prevent hair loss from chemotherapy.

FMH foods may help manage post-acute COVID-19 symptoms safely and easily.

Hyaluronic Acid Profhilo® reduces skin inflammation and nerve-related pain in atopic dermatitis.

SSRIs may help manage sexual behavior in dementia patients, but they can cause long-lasting sexual dysfunction.

A specific gene variant is linked to a higher risk of hair loss from chemotherapy in breast cancer patients.

Microneedle patches could replace injections but need more development for better use in medicine.

Chemotherapy is crucial for treating gynecological cancers but requires careful management due to severe side effects.

Trastuzumab deruxtecan is effective for HER2-positive breast cancer but requires careful management of side effects.

Burn injuries can cause long-term itching, skin color changes, and cancer risks, needing personalized treatment.

Traditional Indian home remedies are effective and culturally important.

Rizatriptan benzoate-loaded dissolving microneedles are effective and convenient for treating acute migraines.

Ovalbumin–aluminum sensitization causes increased pain sensitivity and nerve changes in mice.

Blocking certain brain processes reduces mating behavior in female rats.

Targeting 5α-reductase type 1 may help manage Tourette-like symptoms.

Finasteride reduces certain behaviors caused by D1-like receptor agonists but not by D2-like receptor agonists in mice.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

Compound 4 is a promising treatment for hair loss with low toxicity.

The compound GD-23 may reduce anxiety like diazepam by targeting the TSPO receptor.

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

S5αR inhibitors might help treat schizophrenia and other mental disorders but need more research.

Higher 3α,5α-THP levels in the brain may reduce depression in pregnant rats.

A new compound effectively inhibits human 5α-reductase 1.